# Nephron Pharmaceuticals Corp.

- Location (FDA's records): Orlando, FL
- FDA decisions: 3 (2012–2023): 3 510(k) clearances
- Names in FDA's records: Nephron Pharmaceuticals Corp. (2); Nephron Pharmaceuticals Corporation (1)
- Product codes: CAF (2), LZA (1)
- Predicates its devices cite: 6 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 2 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Holopack International, LP: 1 (https://510kreport.com/company/holopack-international)
- Steripak, Ltd.: 1 (https://510kreport.com/company/steripak)
- Luliang Hongruida Health Protection Technology Co., Ltd.: 1 (https://510kreport.com/company/luliang-hongruida-health-protection-technology)
- Pari Innovative Manufacturers, Inc.: 1 (https://510kreport.com/company/pari-innovative-manufacturers)
- Pharmacaribe: 1 (https://510kreport.com/company/pharmacaribe)
- Dey Laboratories, Inc.: 1 (https://510kreport.com/company/dey-laboratories)

## Firms that cite its devices most
- Pharmacaribe: 1 (https://510kreport.com/company/pharmacaribe)
- Nephron Nitrile, LLC: 1 (https://510kreport.com/company/nephron-nitrile)
- Teleflexmedical, Inc.: 1 (https://510kreport.com/company/teleflexmedical)

## Its most-cited devices
- K113033: Sodium Chlorde Inhalation Solution, 0.9% Usp-3ML (2012), cited by 2
- K223559: Nephron Nitrile Powder-Free Nitrile Examination Gloves (Tested For Use With Chemotherapy Drugs) (2023), cited by 1

## Recent decisions
- K223559: Nephron Nitrile Powder-Free Nitrile Examination Gloves (Tested For Use With Chemotherapy Drugs) (Feb 9, 2023)
- K113033: Sodium Chlorde Inhalation Solution, 0.9% Usp-3ML (Jun 19, 2012)
- K120051: Sodium Chloride Inhalation Solution, 3%, 7%, and 10%, Usp-4ML (Apr 20, 2012)

Source page: https://510kreport.com/company/nephron-pharmaceuticals